Skip to main content

Nexus Pharmaceuticals Launches Fluorescein 2 mL

Nexus Pharmaceuticals, LLC is expanding their Fluorescein dosage options to include Fluorescein Injection, USP 25% in a 2 mL vial alongside Fluorescein Injection, USP 10% in a 5 mL vial. Nexus is committed to enhancing the availability of Fluorescein across the optometry market.

Fluorescein 2 mL and 5 mL are available in cartons of ten. Order your supply of 2 mL Fluorescein Injection, USP 25% directly through your Wholesalers or from Customer Service at (888) 806-4606.

Unit of sale NDC: 14789-0123-05

  • Cencora – 10298239
  • Cardinal – 5977483
  • McKesson – 3020054
  • Morris & Dickson - 594374

About Nexus Pharmaceuticals, LLC: Nexus Pharmaceuticals, LLC., a US-based healthcare company, specializes in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor intensive, and more streamlined in practice. Nexus ensures that its high-quality drug products fulfill a critical unmet medical need and deliver dependable life-saving treatment options when and where they’re needed most.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  221.20
+7.43 (3.48%)
AAPL  258.08
+4.58 (1.81%)
AMD  230.57
+9.04 (4.08%)
BAC  51.55
+1.27 (2.52%)
GOOG  314.79
+10.86 (3.57%)
META  593.98
+18.93 (3.29%)
MSFT  378.07
+5.78 (1.55%)
NVDA  181.59
+3.49 (1.96%)
ORCL  144.23
+1.06 (0.74%)
TSLA  345.36
-1.29 (-0.37%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.